Saturday, July 28, 2012 |
Sunday, July 29, 2012 |
Monday, July 30, 2012 |
Oral Presentations | Oral Presentations | Oral Presentations |
Poster Sessions | Poster Sessions | Poster Sessions |
Monday, July 30, 2012
08:30-11:00 | HALL A | |
PL15 Plenary
Session: Chairs: |
||
08:30 | STEPS TO PREVENT HEART FAILURE (Invited Lecture) H.K. Reddy, University of Arkansas for Medical Sciences, Little Rock, AR, USA |
385 |
08:45 | THYROID HORMONE DYSFUNCTION AND HEART FAILURE: FEAR OF OVERTREATMENT MAY BE CAUSING HARM (Invited Lecture) A.M. Gerdes, New York College of Osteopathic Medicine, Old Westbury, NY, USA |
386 |
09:00 | INTERNATIONAL CLINICAL TRIALS: GOOD FOR THE NEW WORLD BAD FOR THE THIRD WORLD (Invited Lecture) S. Goldstein, Henry Ford Hospital, Detroit, MI, USA |
387 |
09:15 | AGING AND HEART FAILURE: ROLE OF HEALING AFTER MYOCARDIAL INFARCTION (Invited Lecture) B.I. Jugdutt, University of Alberta and Hospitals, Edmonton, Alberta, Canada |
388 |
09:30 | BAROREFLEX STIMULATION FOR THE TREATMENT OF HEART FAILURE (Invited Lecture) H.N. Sabbah, Henry Ford Hospital, Detroit, MI, USA |
389 |
09:45 | NOVEL HEMODYNAMIC RISK FACTORS FOR NEW - ONSET HEART FAILURE IN THE GENERAL POPULATION (Invited Lecture) J.A. Chirinos, University of Pennsylvania School of Medicine Philadelphia, PA, USA |
390 |
10:00 | MANAGEMENT OF PATIENT WITH ADVANCED HEART FAILURE (Invited Lecture) M.H. Pitzalis, East Carolina University, The Brody School of Medicine, Greenville, NC, USA |
391 |
10:15 | BLOOD UREA NITROGEN: AN EMERGING BIOMARKER FOR NEUROHORMONAL ACTIVATION IN HEART FAILURE (Invited Lecture) A. Kazory, University of Florida, Gainesville, FL, USA |
392 |
10:30 | DIET IN THE PREVENTION AND MANAGEMENT OF HEART FAILURE (Invited Lecture) C. Chrysohoou, First Cardiology Clinic, University of Athens, Greece |
393 |
10:45 | INCREASED RENAL ENAC SUBUNITS AND SODIUM RETENTION IN RATS WITH CHRONIC HEART FAILURE (Invited Lecture) H. Zheng, University of Nebraska Medical Center, Omaha, NE, USA |
394 |
11:00 | COFFEE BREAK, VISIT POSTERS AND EXHIBITION | |
MONDAY, JULY 30,2012 | ||
08:30-10:45 | HALL B | |
|
PL16 Plenary Session: NOVEL CARDIOPROTECTIVE THERAPIES Chairs: Y. Birnbaum, Houston, TX, USA P.K. Singal, Winnipeg, MB, Canada |
|
08:30 | EARLY INSULIN TREATMENT AMELIORATES POST-ISCHEMIC HEART FAILURE BY INHIBITION OF MYOCARDIAL CAMKII AND
P38 MAPK ACTIVITY (Invited Lecture) F. Gao, The Fourth Military Medical University, Xi'an, China |
395 |
08:45 | THE ROLE OF MYD88 IN THE ANTI-APOPTOTIC EFFECTS OF INTERLEUKIN-10 (Invited Lecture) P.K. Singal, St. Boniface Hospital Research Centre, Winnipeg, MB, Canada |
396 |
09:00 | AMPLIFICATION OF THE MYOCARDIAL INFARCT SIZE LIMITING EFFECTS OF GLP-1 RECEPTOR ACTIVATION BY CILOSTAZOL,
A PHOSPHODIESTERASE III INHIBITOR (Invited Lecture) Y. Ye, Y. Birnbaum, Baylor College of Medicine, Houston, TX, USA |
397 |
09:15 | MOLECULAR MECHANISMS OF THE BENEFICIAL CARDIOVASCULAR EFFECTS OF TRANS-RESVERATROL (Invited Lecture) U. Forstermann, Johannes Gutenberg University Medical Center, Mainz, Germany |
398 |
09:30 | OXYTOCIN – AN ANTIOBESITY AND CARDIOPROTECTIVE MOLECULE (Invited Lecture) D. Jezova, Institute of Experimental Endocrinology, Bratislava, Slovakia |
399 |
09:45 | LEFT VENTRICULAR FAILURE PRODUCES PROFOUND LUNG REMODELING AND PULMONARY HYPERTENSION: HEART FAILURE
CAUSES SEVERE LUNG DISEASE (Invited Lecture) Y. Chen, University of Minnesota, Minneapolis, MN, USA |
400 |
10:00 | THERAPEUTIC POTENTIAL OF TISSUE INHIBITOR OF METALLOPROTEINASES (TIMPS) FOLLOWING MYOCARDIAL
INFARCTION (Invited Lecture) |
401 |
10:15 | TRICYCLIC PSYCHIATRIC ANTIDEPRESSANTS AS ALPHA2A ADRENERGIC RECEPTOR LIGANDS MODULATING RECEPTOR FUNCTION (Invited Lecture) Q. Wang, University of Alabama at Birmingham, AL, USA |
402 |
10:30 | THE INFLUENCE OF ACUTE MATRIX METALLOPROTEINASE ACTIVITY ON MYOCARDIAL DYSFUNCTION ASSOCIATED WITH URGENT CARDIAC SURGERY: CARDIOPROTECTIVE EFFECTS OF INHIBITION E.S. Teh, D.J. Chambers The Rayne Institute (King's College London), London, UK |
403 |
10:45 | COFFEE BREAK, VISIT POSTERS AND EXHIBITION | |
MONDAY, JULY 30,2012 | ||
08:30 - 10:15 | HALL C | |
S33 Session: INTERVENTIONAL CARDIOLOGY Chairs: B.F. Uretsky, Little Rock, AR, USA G.W. Vetrovec, Richmond, VA, USA |
||
08:30 | DEDICATED STENT TREATMENT VERSUS STANDARD TREATMENT FOR CORORNARY BIFURCATIONS: LONG-TERM FOLLOW-UP T. Gil-Jimenez, L.A. Inigo-Garcia, J.R. Siles-Rubio, A. Ramirez-Moreno, L. Fernandez-Lopez, C. Medina-Palomo, M. Pombo-Jimenez, J.F. Munoz-Bellido, O. Sanz-Vazquez, F. Ruiz-Mateas, Hospital Costa de Sol, Marbella, Spain |
404 |
08:45 | A MULTIDISCIPLINARY EFFORT TO DECREASE VASCULAR COMPLICATIONS FOLLOWING PERCUTANEOUS CORONARY
INTERVENTION (PCI) P. Muthusamy, D. Busman, D. Wohns, Grand Rapids Medical Education Partners, Grand Rapids, MI, USA |
405 |
09:00 | META-ANALYSIS OF TRIALS INVOLVING CHRONIC TOTAL OCCLUSIONS M. Khan, M-R. Movahed, The Southern Arizona VA Health Care System, University of Arizona Sarver Heart Center, Tucson, AZ, USA |
406 |
09:15 | TRANSRADIAL CATHETERIZATION AND M-SIGN G.H. Abusaid, W.I. Khalife, University of Texas Medical Branch, Galveston, TX, USA |
407 |
09:30 | ADJUNCTIVE USE OF CORONARY EXCIMER LASER FOR LESIONS UNSUCCESSFULLY CROSSED WITH CORONARY BALLOONS A. Singh, G. Srinivas, S. Singhal, D. Jauhar, B. Kaplan, R. Jauhar, B. Arkonac, Long Island Jewish Medical Center, New Hyde Park, NY, USA |
408 |
09:45 | GENDER AND AGE PREDICT HYPORESPONSIVENESS TO CLOPIDOGREL BY PLATELET FUNCTION TESTING IN EMERENCY DEPARTMENT
H.K. Reddy, R. Sharma, S.W. Erickson, D.J. Voelker, M. Moazazi, H. Dod, V.N. Singh, J.D. Marsh, R.K. Sharma, University of Arkansas for Medical Sciences, Little Rock, AR, USA |
409 |
10:00 | CLINICALLY RELEVANT COMPOSITE OUTCOMES IN THE TREATMENT OF SYMPTOMATIC CORONARY ARTERY DISEASE (CAD)
E.L. Woollard, L.J. Wood, K.V. Woollard, T.G. Briffa, University of Western Australia, Perth WA, Australia |
410 |
10:15 | COFFEE BREAK, VISIT POSTERS AND EXHIBITION | |
MONDAY, JULY 30,2012 | ||
11:15-14:00 | HALL A | |
PL17 Plenary
Session: Chairs: |
||
11:15 | THE OBESITY PARADOX AND CARDIOVASCULAR DISEASE (Invited Lecture) M.A. Alpert, University of Missouri-Columbia School of Medicine, Columbia, MO, USA |
411 |
11:30 | ENDOTHELIAL DYSFUNCTION IN HYPERTENSION, DIABETES AND OBESITY (Invited Lecture) T. Malinski, Chemisty and Biochemistry Ohio University, Athens, OH, USA |
413 |
11:45 | SCREENING FOR CVD IN METABOLIC SYNDROME AND DIABETES? (Invited Lecture) N.D. Wong, Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, CA, USA |
414 |
12:00 | CARDIOVASCULAR DISEASE PREVENTION IN PATIENTS WITH DIABETES (Invited Lecture) G.L. Fung, UCSF Medical Center at Mt. Zion, San Francisco, CA, USA |
415 |
12:15 | REFINING RISK ASSESSMENT IN DIABETIC DYSLIPIDEMIA AFTER ACHIEVING LDL-C GOAL (Invited Lecture) O.P. Ganda, Harvard Medical School, Boston, MA, USA |
485 |
12:30 | NON-INVASIVE ULTRASOUND EVALUATION OF SUBCLINICAL ATHEROSCLEROSIS: PROGRESS AND PITFALLS (Invited Lecture) J.M. Gardin, Hackensack University Medical Center, Hackensack, NJ, USA |
416 |
12:45 | GENETIC RISK FACTORS FOR CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES (Invited Lecture) L. Qi, Harvard School of Public Health, Boston, MA, USA |
417 |
13:00 | EFFICACY AND SAFETY OF SAXAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES AND HISTORY OF CARDIOVASCULAR DISEASE
W. Cook, B. Bryzinski, J. Slater, M. Donovan, E. Allen, Medical Affairs, AstraZeneca, Wilmington, DE, USA |
418 |
13:15 | ELEVATED AMBULATORY PULSE PRESSURE IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES: THE HYGIA PROJECT
D.E. Ayala, A. Moya, S. Gomara, J.J. Crespo, M.C. Castineira, J.J. Sanchez, M. Dominguez, A. Mojon, J.R. Fernandez, R.C. Hermida, University of Vigo, Spain |
419 |
13:30 | AMBULATORY BLOOD PRESSURE THRESHOLDS FOR DIAGNOSIS OF HYPERTENSION IN TYPE 2 DIABETES BASED ON
CARDIOVASCULAR OUTCOMES R.C. Hermida, D.E. Ayala, A. Mojon, J.R. Fernandez, University of Vigo, Spain |
420 |
13:45 | EFFICACY AND SAFETY OF SAXAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES STRATIFIED BY CARDIOVASCULAR RISK FACTORS
W. Cook, J. Slater, B. Bryzinski, M. Donovan, E. Allen Medical Affairs, AstraZeneca, Wilmington, DE, USA |
421 |
14:00 | LUNCH BREAK, VISIT POSTERS AND EXHIBITION | |
MONDAY, JULY 30,2012 | ||
11:15-13:45 | HALL B | |
|
S34 Session: HEART FAILURE: PATHOGENESIS, MANAGEMENT, OUTCOMES Chairs: B.I. Jugdutt, Edmonton, AB, Canada M.H. Pitzalis, Greenville, NC, USA |
|
11:15 | BIOIMPEDANCE VECTOR ANALYSIS IN THE DIAGNOSIS OF ACUTE DECOMPENSATED HEART FAILURE IN THE EMERGENCY DEPARTMENT D.W. Kehl, R. Choudhary, B. Dieffenbach, P. Clopton, P.R. Taub, A.S. Maisel, University of California at San Diego, San Diego, CA, USA |
422 |
11:30 | THE ROLE OF RIGHT VENTRICULAR FUNCTION IN PEDIATRIC IDIOPATHIC DILATED CARDIOMYOPATHY
A. Groner, J. Yu, H. Ko, J. Nielsen, I. Lytrivi, I. Parness, S. Srivastava Mount Sinai Medical Center, New York, NY, USA |
423 |
11:45 | IS "CHRONOTROPIC INCOMPETENCE" AN ADAPTIVE MECHANISM IN SYSTOLIC HEART FAILURE?
J. Shirani, T.H. LeJemtel, St. Luke's University Health Network, Bethlehem, PA, USA |
424 |
12:00 | PROGNOSTIC UTILITY OF QRS FRAGMENTATION IN PATIENTS WITH NON ISCHEMIC CARDIOMYOPATHY
V.M. Alla, O. Bansal, S. Kanuri, M.B. Jayanna, Y.M. Reddy, M. Kaushik, D. Lakkireddy, A. Mooss, Creighton University, Omaha, NE, USA |
425 |
12:15 | TAKOTSUBO CARDIOMYOPATHY AND STROKE M.L. Young, J. Stoehr, M.I. Aguilar, F.D. Fortuin, Midwestern University, Glendale, AZ, USA |
426 |
12:30 | MICRORNAS AS A WINDOW INTO CELLULAR PROCESSES OCCURRING SOON AFTER ACUTE MYOCARDIAL INFARCTION C. Watt, P. Sirish, N. Chiamvimonvat, J. López University of California, Davis, Sacramento, CA, USA |
427 |
12:45 | EVALUATION OF ATRIAL ASYNCHRONY IN HEART FAILURE PATIENTS BY 2D SPECKLE TRACKING USING VELOCITY VECTOR
IMAGING
M. Esmaeilzadeh, M. Nikparvar, M. Maleki, F. Noohi, S.Z.M. Ojaghighi Haghighi, P. Nakhostin Davari, H. Bakhshandeh Tehran University of Medical Sciences, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran |
428 |
13:00 | FREQUENCY OF IMPLANTABLE DEFIBRILLATOR (ICD) USE IN SEVERE SYSTOLIC HEART FAILURE AND EFFECTS ON MORTALITY R. Al-Najjar, T. Abu Sharifeh, A. Al Emam, A. Khanfar, W.I. Khalife, University of Texas Medical Branch, Galveston, TX, USA |
429 |
13:15 | BETA BLOCKER UPTITRATION POST CRT: A SINGLE CENTER EXPERIENCE F.A. McGrew, E.E. Johnson, M.A. Coppess, J. Foon, S.B. Charlton, T.A. Charlton, J.J. Sims, Stern Cardiovascular Clinic, Germantown, TN, USA |
430 |
13:30 | PROBNP AND TROPONIN COMBINED IS A STRONGER PREDICTOR OF READMISSIONS COMPARED TO PROBNP ALONE IN CHF PATIENTS N.C. Bhalodkar, A. Alvi, R. Alvi, U. Khan, J. N. Bella, M. Afshar, Bronx-Lebanon Hospital Center affiliated with Albert Einstein College of Medicine, Bronx, NY, USA |
431 |
13:45 | LUNCH BREAK, VISIT POSTERS AND EXHIBITION | |
MONDAY, JULY 30,2012 | ||
11:15 - 13:45 | HALL C | |
S35 Session: ACUTE CORONARY SYNDROMES: DETECTION, PREVENTION AND TREATMENT Chairs: M.E. Farkouh, Toronto, ON, Canada Y. Ueda, Osaka, Japan |
||
11:15 | DIABETES MELLITUS IS A PREDICTOR OF HYPORESPOSIVENESS TO CLOPIDOGREL BY PLATELET FUNCTION TESTING IN EMERGENCY
ROOM R.K. Sharma, S.W. Erickson, R. Sharma, D.J. Voelker, F. Forsea, H. Dod, V.N. Singh, H.K. Reddy, J.D. Marsh, University of Arkansas for Medical Sciences, Little Rock, AR, USA |
432 |
11:30 | MRI EVALUATION OF LEFT VENTRICULAR FUNCTION POST CORONARY OCCLUSION/REPERFUSION AND EMBOLIZATION IN SWINE MODEL M. Saeed, S.W. Hetts, L. Do, S.M. Sullivan, M.W. Wilson University of California San Francisco, CA, USA |
433 |
11:45 | ANTIDEPRESSANT USE, SEROTONIN TRANSPORTER AFFINITY, AND REINFARCTION AMONG PATIENTS RECEIVING CLOPIDOGREL:
A POPULATION-BASED STUDY N. Fnais, M. Alshaikh, Z. Yao, T. Gomes, D. Juurlink, M. Mamdani, King Saud University, Riyadh, Saudi Arabia |
434 |
12:00 | SERUM CORIN IS REDUCED AND PREDICTS ADVERSE OUTCOME IN NON S-T ELEVATION ACUTE CORONARY SYNDROME
A. Peleg, Y. Hasin, Poriya Hospital, Tiberias, Israel |
435 |
12:15 | TRANSRADIAL PERCUTANEOUS CORONARY ANGIOPLASTY IN ACUTE
MYOCARDIAL INFARCTION
J.M. Telayna, R.A. Costantini, C. Garcia, Hospital Universitario Austral, Buenos Aires, Argentina |
436 |
12:30 | A SINGLE CENTER REAL WORLD COMPARISON OF PROCEDURE TIMES
IN THE TRANSRADIAL AND TRANSFEMORAL APPROACHES TO
PRIMARY PCI M.J. Martinelli, K.M. Forbush, M.E. Sturm, C.L. Lasky, M. Fecko, St. Peter's Hospital, Albany, NY, USA |
437 |
12:45 | DIFFERENCES IN THE USE OF CARDIAC PROCEDURES BETWEEN WOMEN AND MEN FOLLOWING HOSPITAL ADMISSION WITH ACUTE MYOCARDIAL INFARCTION: IS THE GAP GETTING NARROWER?
N.N. Singh, V.N. Singh, J. Levine, N.N. Singh, M. Nelson, L. Marlow, Suncoast Cardiovascular Research, St Petersburg, FL, USA |
438 |
13:00 | CHALLENGES IN THE MANAGEMENT OF POSTPARTUM SPONTANEOUS CORONARY ARTERY DISSECTION A.G. Truesdell, J. Li, G.A. Delgado, J.D. Abbott, M.K. Atalay, A.K. Singh Warren Alpert Medical School of Brown University, Providence, RI, USA |
439 |
13:15 | ETHNIC VARIATIONS IN PRESENTATION AND DOOR TO BALLOON TIME IN PATIENTS WITH STEMI
K. Heretis, E. Shlofmitz, M. Balek, C. Park, A.J. Buda New York Hospital of Queens, Weill-Cornell Medical College, New York, NY, USA |
440 |
13:30 | REVASCULARIZATION WITH PERCUTANEOUS TECHNIQUES OR SURGERY IS ASSOCIATED WITH IMPROVED IN-HOSPITAL SURVIVAL IN ELDERLY PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL
INFARCTION
V.N. Singh, N.N. Singh, J. Levine, N.N. Singh, M. Nelson, L. Marlow University of South Florida College of Medicine, Tampa, FL, USA |
441 |
13:45 | LUNCH BREAK, VISIT POSTERS AND EXHIBITION |